Search Results for: TCF12

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ACTB actin beta
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Gap junction degradation
  • Formation of annular gap junctions
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • HATs acetylate histones
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Folding of actin by CCT/TriC
  • EPHB-mediated forward signaling
  • EPH-ephrin mediated repulsion of cells
  • Adherens junctions interactions
  • Adherens junctions interactions
  • Recycling pathway of L1
  • Recycling pathway of L1
  • VEGFA-VEGFR2 Pathway
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • Cell-extracellular matrix interactions
  • B-WICH complex positively regulates rRNA expression
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate Formins
  • RHO GTPases Activate Formins
  • MAP2K and MAPK activation
  • UCH proteinases
  • DNA Damage Recognition in GG-NER
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Clathrin-mediated endocytosis
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • Quercetin
  • Phenethyl Isothiocyanate
  • Other phagocyte defects, including the following eight diseases: Chediak-Higashi syndrome; Griscelli syndrome, type 1 (GS1); Griscelli syndrome, type 2 (GS2); Griscelli syndrome, type 3 (GS3); beta-actin deficiency; Neutrophil-specific granule deficiency; Myeloperoxidase deficiency; Glucose 6-phosphate dehydrogenase deficiency; Shwachman syndrome
Novel ADAM10 ADAM metallopeptidase domain 10
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Signaling by EGFR
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • EPH-ephrin mediated repulsion of cells
  • Neutrophil degranulation
  • Post-translational protein phosphorylation
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • NOTCH4 Activation and Transmission of Signal to the Nucleus
  • Amyloid fiber formation
  • XL784
Novel BCL2L10 BCL2 like 10
Novel MAPK6 mitogen-activated protein kinase 6
  • MAPK6/MAPK4 signaling
  • Acetylsalicylic acid
  • Minocycline
Novel RSL24D1 ribosomal L24 domain containing 1
  • (S)-3-phenyllactic acid
  • Anisomycin
  • Puromycin
Novel SCG3 secretogranin III
  • Platelet degranulation
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
Novel SLC12A1 solute carrier family 12 member 1
  • Cation-coupled Chloride cotransporters
  • Defective SLC12A1 causes Bartter syndrome 1 (BS1)
  • Torasemide
  • Methyclothiazide
  • Chlorthalidone
  • Chlormerodrin
  • Furosemide
  • Potassium chloride
  • Hydroflumethiazide
  • Bumetanide
  • Etacrynic acid
  • Quinethazone
  • Piretanide
  • Bartter syndrome
Novel SLC24A1 solute carrier family 24 member 1
  • Activation of the phototransduction cascade
  • Sodium/Calcium exchangers
  • Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)
Novel SPTBN5 spectrin beta, non-erythrocytic 5
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • RAF/MAP kinase cascade
  • COPI-mediated anterograde transport
Novel YKT6 YKT6 v-SNARE homolog
  • COPII-mediated vesicle transport
  • COPI-mediated anterograde transport
  • Intra-Golgi traffic
ARL16 ADP ribosylation factor like GTPase 16
ARMC8 armadillo repeat containing 8
  • Neutrophil degranulation
ASCL3 achaete-scute family bHLH transcription factor 3
ASCL4 achaete-scute family bHLH transcription factor 4
BMERB1 bMERB domain containing 1
BMF Bcl2 modifying factor
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Activation of BMF and translocation to mitochondria
C1orf109 chromosome 1 open reading frame 109
CDKN2C cyclin dependent kinase inhibitor 2C
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Cyclin D associated events in G1
CFAP206 cilia and flagella associated protein 206
CKS1B CDC28 protein kinase regulatory subunit 1B
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin D associated events in G1
  • Fluoxetine
  • 2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium

Page 1 out of 5 pages